NCT02858245View on ClinicalTrials.gov

A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device

TerminatedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Mitral Regurgitation
Interventions
OTHER

No intervention - registry

Trial Locations (8)

23226

Bon Secours St Mary's Hospital, Richmond

28203

Carolinas Medical Center, Charlotte

33176

Baptist Hospital of Miami, Miami

44195

The Cleveland Clinic Foundation, Cleveland

55905

Mayo Foundation for Medical Education and Research, Rochester

80045

University of Colorado Hospital, Aurora

85006

Banner University Medical Center, Phoenix

90048

Cedars-Sinai Medical Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT02858245 - A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device | Biotech Hunter | Biotech Hunter